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Abstract: Genotoxic effects of Mimosa tenuifl ora (Willd.) Poir, Fabaceae, were 
investigated by using both micronucleus test and bacterial reverse mutation assay in 
Salmonella typhimurium TA97, TA98, TA100, TA102 respectively. In respect of Ames 
test results show that the extract does not induce mutations in any strains of Salmonella 
typhimurium tested since the mutagenicity index is less than 2. In the antimutagenic 
effect was observed that the extract at the concentrations tested signifi cantly decreased 
the mutagenicity index of all strains tested which characterized the extract as 
antimutagenic in these conditions. In the micronucleus test in vivo, we observed that 
the concentrations used did not induce an increase in the frequency of micronucleus in 
normochromatic erythrocytes of mice. Therefore, we concluded that the extract of M. 
tenuifl ora is not mutagenic in the absence of exogenous metabolizing system and does 
not induce an increase in the frequency of the micronucleus characterized as an agent 
not mutagenic in these conditions. Further studies of toxicity need to be made to the 
use of this plant in the treatment of diseases to be stimulated.
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Introduction
 The healing power of plants is as old as the 
emergence of the human species on earth. Early, the 
fi rst civilizations noticed that some plants contain in 
their essence, the active ingredients which are tested in 
combating disease empirically proved its healing power 
(Badke et al., 2011). On this basis, it is very important to 
carry out toxicity studies on plant-based extracts, as some 
of its biologically active constituents may be toxic to the 
body and contain chemicals known to be mutagenic or 
carcinogenic.
 The lack of adequate information on the medicinal 
properties of plants (mainly exotic), its concomitant use 
with traditional medicines (allopathic) without notice to the 
doctor, and fi nally the loss of knowledge about the effects 
of medicinal and toxic plants, as well as the ability to 
identify them by the migration of rural population to cities 
are worrying factors in the use of medicinal plants without 
previous studies (Veiga Júnior et al., 2005; Albuquerque & 
Hanazaki, 2006).
 Genetic toxicology tests are assays designed 
to detect direct or indirect genetic damage induced by 
chemical compounds. Fixation of DNA damage can result 
in gene mutations, loss of heterozygosity, chromosome 
loss or gain, and chromosome aberrations. These events 
may play an important role in many malignancies. Thus, 
identifying genotoxic/mutagenic effects is important for 
the risk/benefi t assessment of substances, in particular 
those which are part of the dietary habits of any populations 
(Doppalapudi et al., 2007).
 Examining the mutagenicity of plant extract 
or chemical(s), Ames test, or the so-called Salmonella/
microsome test, is widely used (Konuk et al., 2008; Uysal 
et al., 2010; Liman et al., 2010). This test can be carried out 
rapidly and cheaply and it is also one of the most reliable 
short-term bacterial test systems (Maron & Ames, 1983; 
Mortelmans & Zeiger, 2000). A compound is considered 
mutagenic when the increase in dose is directly related to 
the increase in number of colonies mutated in one or more 
strains of Salmonella typhimurium dependent histidine 
(Mortelmans & Zeiger, 2000). 
 Despite the valuable contribution to the control 
of many diseases, the use of drugs in medical practice 
produces undesirable effects, including carcinogenesis. 
The micronucleus test in vivo is widely accepted by 
international agencies and government institutions as 
part of the recommended battery of tests to establish 
the evaluation and registration of new chemicals and 
pharmaceutical annually entering the world market and 
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that may have mutagenic activity (Ribeiro & Marques, 
2003) 
 Mimosa tenuiflora (Willd.) Poir., Fabaceae, is a 
perennial evergreen tree or shrub native of Northeast Brazil 
where is popularly known as ''jurema-preta''. It is used in 
folk medicine against bronchitis, coughs, fever, headache 
and external ulcers, and in Indigenous and Afro-Brazilian 
cults as entheogen (Albuquerque et al., 2007; Agra et al., 
2008; Souza et al, 2008). Phytochemical investigations of 
M. tenuiflora resulted in the isolation of several classes of 
compounds, including indole alkaloids, tannins, chalcones, 
steroids, terpenoids and phenoxychomones (Rivera-Arce 
et al., 2007; Souza et al., 2008).
 Considering the absence of studies on the toxic 
effects of this plant, the aim of the present study was to 
evaluate the mutagenic /antimutagenic and genotoxic 
activities M. tenuiflora using the Ames test and the 
micronucleus test on peripheral blood cells.
Materials and Methods
Chemicals
 Ethanol, methanol, D-glucose-6-phosphate 
disodium salt, magnesium chloride, L-histidine 
monohydrate, D-biotin, sodium and 4-nitroquinoline 
1-oxide were purchased from Sigma Chemical Co (St. 
Louis,USA). Nutrient Broth medium (Difco/USA) was 
used as bacterial media. Agar (Difco/USA) was used in 
the Ames test.
Plant materials
 The steam bark of Mimosa tenuiflora (Willd.) 
Poir, Fabaceae, was collected in March 2010 at the Center 
for Rural Health and Technology, Patos Campus UFCG-
Paraíba, Brazil and identified by Denise Aline Cassimiro 
Bezerra (UFPB). The voucher specimen (#3274) of the 
plant was deposited in the Herbarium Caririensis Dardanus 
de Andrade Lima, the Cariri Regional University - URCA, 
Crato-CE, Brazil.
Animals treatment
 The use of animals was approved by the 
Ethics Committee for Animal Research Laboratory of 
Pharmaceutical Technology UFPB under registration 
number 0206/11. For the realization of experimental models 
were used five to six-week old albino Swiss mice (Mus 
musculus), weighing approximately 30 g from the Biotery 
Prof. Thomas George UFPB. The animals were acclimated 
to the bioterium local conditions for about seven days 
before the experimental tests under temperature (21±2 °C) 
and controlled light-dark cycle of 12 h. The animals were 
fed chow and water ad libitum and were distributed in the 
different experimental groups at random.
Preparation of crude ethanolic extract of Mimosa 
tenuiflora
 The steam bark of M. tenuiflora were dried in an 
oven with circulating air average temperature of 45 ºC for 
3 to 4 days, and then subjected to a process of spraying 
in mechanical mill, reducing it to powder. The dried and 
powdered plant material, weighing 430 g, was subjected to 
exhaustive maceration with 2 L of EtOH at 95% for 72 h, 
this process being repeated three times to obtain maximum 
extraction of chemical constituents. The resulting extraction 
solution, after filtration, was concentrated with the aid of a 
rotary evaporator under reduced pressure at a temperature 
not exceeding 40 ºC, resulting in a 22% income.
Phytochemical screening of extract of Mimosa tenuiflora
 Initially, the extract was analyzed by 
phytochemical screening for the identification of several 
classes of secondary metabolites. It was subsequently 
analyzed by thin layer chromatography for the detection 
of phenols. Chromate aluminum silica gel plates F 254 
(Merck®, Darmstadt, Germany) were used. Flavonoids 
were analyzed using ethyl acetate:formic acid:water 
(8:1:1, v/v) as mobile phase natural and reagent A (1%) 
and UV 365 nm as developer. For tannins, were used as 
mobile phase ethyl acetate:formic acid:water (9:0,5, 0.5 
v/v) and toluene:acetone:acetic acid (6:2:2, v/v) , ferric 
chloride (5%) for visualization of the spots. We used 
chromatographic standards of tannins gallic acid, ellagic 
acid, tannic acid, catechin and epicatechin and flavonoids 
isoquercetina, isovitexin, quercetin, rutin and vitexin 
(Extrasynthese and Sigma) (Wagner & Bladt, 1996).
 For phytochemical analysis, it was used the 
methodology proposed by Matos (1995) which consists 
of a phytochemical semi-quantitative, based on color and 
precipitation reactions specific for each class of constituents 
being analyzed. The crosses classification proposed by 
the same author is the intensity in rate of reaction and 
correlating the amount of constituents present, and thus a 
semi-qualitative estimation. Example: For detection of the 
reaction of tannin was used the technique of precipitation 
of gelatin. The presence of light (+), moderate (+ +) or 
severe (+ + +) tannin is represented fairly according to the 
intensity of these reactions (formation of precipitate).
Ames mutagenic/antimutagenic test
 The mutagenicity was evaluated using part of 
the methodology described by Maron & Ames (1983). 
Selection of the strains was based on the testing and strain 
selection strategies of Mortelmans & Zeiger (2000).
 Suspensions in Nutrient Broth medium (DIFCO) 
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of mutant strains of S. typhimurium TA97, TA98, TA100, 
TA102, in stationary phase, which carry different 
mutations in various genes of the histidine operon (His-) 
were incubated with concentrations of 100 and 50 μg.mL-1 
of extract of M. tenuiflora at a temperature of 37 °C in the 
absence of exogenous metabolizing system S9 (-S9).  These 
concentrations were used (below the minimum inhibitory 
concentration) because the extract showed antibacterial 
activity against Salmonella strains tested with MIC of 250 
μg.mL-1.
 After 30 min, the samples were plated on minimal 
agar medium, 20 mL Vogel-Bonner medium (10 g MgSO4.
H20, 100 g citric acid monohydrate, 500 g K2HPO4, 175 g 
Na2NH2PO4.4H2O to 1 L), 50 mL glucose 10% v/v, 15 g 
agar to 1 L) and incubated at 37 °C for 48 h. Mutant colonies 
(His+) that restored its capacity to synthesize histidine 
(revertants) were counted. Suspensions were plated S. 
typhimurium as a negative control and suspensions of S. 
typhimurium incubated in the presence of 4-nitroquinoline 
1-oxide (NQNO) (0.5 μg/plate) (Sigma), as positive 
control.
 To investigate whether the extract of M. 
tenuiflora has antimutagenic activity, suspensions of 
S. typhimurium (TA97, TA98, TA100, TA102) were 
subjected to two concentrations of the product (100 and 
50 μg.mL-1) at 37 °C for 30 min. Then the samples were 
incubated in the presence of 4-nitroquinoline 1-oxide for 
30 min, plated on minimal agar medium and maintained 
at 37 °C for 48 h.
 All experiments were performed in triplicate and 
results expressed as mutagenicity index. The mutagenicity 
index (MI) was also calculated for each dose. MI is the 
average number of revertants per plate divided by the 
average number of revertants per plate from the negative 
(solvent) control. A sample was considered positive when 
the MI≥2 for at least one of the tested doses and if it gave 
a reproducible dose-response curve (Varella et al., 2004; 
Santos et al., 2008). Extracts that presented concentrations 
that induces significant difference in comparison to 
negative control revertants frequency and MI higher than 
1.5 and lower than 2 were considered as a weak mutagen 
(Mortelmans & Zeiger, 2000).
Micronucleus test 
 To perform the micronucleus test, the animals 
were sacrificed with xylazine (5 mg/kg) in accordance 
with existing regulations to prevent anxiety or fear (stress) 
(Andrade et al., 2006) and then blood samples were 
collected from the caudal vein of mices.
 The micronucleus test on peripheral blood cells 
was carried out as described by Hayashi et al. (1994), 
who concluded that bone marrow cells can be replaced by 
peripheral blood as material for the micronucleus assay. This 
is allowed because, alternatively in mice, the micronuclei 
can be analyzed in circulating normochromatic erythrocytes 
(NCE, erythrocytes), whereas the spleen of mice did not 
hijack the blood micronucleated erythrocytes.
 Groups of three mices males and three females 
received, by gavage, the crude extract of M. tenuiflora 
in dose of 100 to 200 mg/kg of animal weight because 
according to Pereira (2010) the extract of M. tenuiflora has 
LD50 500 mg/kg. The negative control group received only 
the dispersant of the sample (distilled water) and positive 
control received Cyclophosphamide 50 mg/kg of animal 
weight. Twenty-four hours after treatment, the animals 
were sacrificed, blood was collected from the caudal vein 
and made a smear on the slide. 
Analysis of the slides
 The slides were stained with Panotic and 
observed under an optical microscope (Zeiss) increasing 
1000x (objective 100x with eyepiece 10x) for counting the 
micronucleus. Were assessed at least 2,000 NCE per slides 
(Hayashi et al., 1994). 
 In this study, the presence of micronucleus 
in erythrocytes of mice in the positive control was not 
influenced by gender (p>0,05), so data were pooled to 
determine the average number of micronucleus to calculate 
the standard error of the mean and to assess differences 
between groups.
 The data from the micronucleus assay were 
statistically analyzed using Student’s t-test, comparing 
the treated groups with controls (Pereira, 1991). The 
significance level considered was p<0.05. Results were 
expressed as mean±SEM.
Results and Discussion
 Living organisms are often exposed to mutagenic 
substances, and many of them may have a natural origin, 
such as example of herbal medicines. Since many extracts 
and active principles of plants already described have 
been used as therapeutic agents for considerable interest 
in determining the risk they may cause health, leading 
to diseases or even death in animals and humans. Thus, 
evaluation of mutagenic and/or genotoxic potential were 
required to ensure the use of relatively safe plants man 
medicinal as is the case of Mimosa tenuiflora (Willd.) Poir, 
Fabaceae, (Surh & Ferguson, 2003).
 Through phytochemical prospecting of the 
extracts, it was possible to determine the presence of diverse 
classes of secondary metabolites. The results revealed 
a wide variety of chemical constituents highlighting 
the presence of saponins, gums, resins, and particularly 
phenols (among the flavonoids and tannins) supporting 
the studies pharmacochemical of Camargo-Ricalde (2000) 
and Bezerra (2008). The extract of M. tenuiflora also 
showed moderate presence of alkaloids, flavonoids and 
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pyrogallic tannins; thioglycosides traits were observed and 
the absence of mucilage, quinones, coumarins, lactones, 
steroid, carotenoids, catechins and resins. These results 
corroborate the studies of Meckes-Lozoya et al. (1990a). 
 Some studies confirm the presence of saponin in 
the stem of M. tenuiflora. Antón et al. (1993) have isolated 
and identified three new triterpenoid saponins and three 
steroidal saponins. Total saponin concentration in the 
whole extract of M. tenuiflora was ca. 0.15% (being 0.10% 
for mimonoside A; 0.032% for mimonoside B; and 0.016% 
for mimonoside C). The three steroidal saponins were 3-O-
β-D-glucopyranosyl campesterol, 3-O-β-D-glucopyranosyl 
stigmasterol and 3-O-β-D-glucopyranosyl-β-sitosterol) of 
the stem of M. tenuiflora.
 Meckes-Lozoya et al. (1990b) also claim that 
the abundance of tannins and flavonoids found in the 
extract of “jurema-preta” factor is probably responsible 
for the observed antimicrobial activity in Staphylococcus 
epidermidis, Escherichia coli, Pseudomonas aeruginosa 
and Acinetobacter calcoaceticus.
 The Ames test is widely used as a screening 
method to determine the mutagenic potential of new 
chemical compounds and drugs since there is a high 
correlation between positive response in test genetic 
toxicity and carcinogenicity, both in rodents and in humans 
(McCann et al., 1975; Purchase et al., 1978; Mortelmans & 
Zeiger, 2000).
 The crude extract of M. tenuiflora in the 
concentration of 100 and 50 μg.mL-1 did not induce 
mutations in strains of S. typhimurium tested  since the 
mutagenicity ratio is less than 2 (Table 1), so the extract 
of M. tenuiflora is not considered mutagenic in these 
conditions evaluated. 
 The treatment of strains of S. typhimurium with 
crude ethanol extract of M. tenuiflora before incubation 
with the mutagenic agent (4-nitroquinoline 1-oxide) 
showed an antimutagenic effect on strains TA97, TA100 
and TA102 since the mutagenicity ratio is less than 2 
(Table 2). In strain TA98, even the mutagenicity index 
was greater than 2, it is observed that there was a large 
reduction of mutagenicity index what characterizes an 
antimutagenic effect. 
 The antimutagenic activity of the extract of M. 
tenuiflora is certainly related to the abundance of tannins 
present in this species (Meckes-Lozoya et al., 1990a) 
that, according to Dauer et al (2003), has antimutagenic 
activity.
 The assessment of micronucleus induction is the 
primary in vivo test in a battery of genotoxicity tests and 
is recommended by law enforcement agencies worldwide 
as part of the safety assessment of chemicals and natural. 
The test, when performed correctly, detects both effects: 
clastogenic and aneugenic (Krishna & Hayashi, 2000).
 According Cammerer et al (2007) the 
micronucleus assay done in peripheral blood has further 
advantages, such as the easy preparation of the sample 
small amount of blood, the speed in obtaining results, the 
ability to obtain repeated samples of the same animal, and 
the possibility of obtaining samples studies chronic.
 Micronucleus in young erythrocytes emerge 
primarily from acentric fragments or chromosomes that 
are unable to migrate following the mitotic spindle during 
cell division of hematopoietic tissue (Salamone & Heddle, 
1983; Ouanes et al., 2003). An increase in frequency 
micronucleus test animals treated with different substances 
is an indication of chromosomal damage induced (Krishna 
& Hayashi, 2000). Micronuclei are indicative of numerical 
and/or structural chromosome aberrations during cell 
mitosis. Other authors have used the micronucleus test as 
a biomarker for chromosome instability and malignancy, 
observing higher frequencies of micronucleated cells 
among cancer patients than among healthy individuals 
(Kamboj & Mahajan, 2007; Lou et al., 2007). 
 The results showed that both at the dose of 100 
to 200 mg/kg of the extract of M. tenuiflora did not induce 
a significant increase in the numbers of micronucleus in 
relation to the negative control (p>0,05) not presenting, 
therefore, clastogenic and aneugenic effect. Only 
cyclophosphamide (positive control) induced a significant 
increase in the amount of micronucleus (p<0,05) (Table 
3).
 Della Torre (2011) investigated the mutagenicity 
of the extract of Plathymenia reticulata Benth 
(Leguminosae) against strains of S. typhimurium TA100, 
Table 1. Mutagenic effect of the extract of Mimosa tenuiflora on strains of S. typhymurium. The results are expressed as mutagenicity 
index and number of revertants colonies per plate (mean±standard error of mean).
Experimental group MI (TA 97) MI (TA 98) MI (TA100) MI (TA 102)
NQNOa (positive control) 2.37 33.09 13.07 8.98
Revertants/plates (UFC) 316±3,5 320±4,7 932±2,4 348±2,3
Extract 100 μg.mL-1 0.42 0.26 0.41 0.42
Revertants/plate (UFC) 93±2,6 7±2,1 21±5,7 30±3.2
Extract 50 μg.mL-1 0.36 0.73 0.37 0.35
Revertants/plate(UFC) 80±4,6 19±3,2 19±2,5 25±2,6
Values in brackets (MI) ≥2 indicate mutagenicity. NQNO- 4-nitroquinoline 1-oxide.
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TA98, TA97a, and TA102. Species of this family are 
known to have high levels of flavonoids and tannins in its 
constitution. The extract was mutagenic for strain TA98 
and showed signs of mutagenicity for TA102 and TA97.
 Through the results obtained it can be concluded 
that the extract of M. tenuiflora is not mutagenic in the 
absence of exogenous metabolizing system and does not 
induce an increase in the frequency of the micronucleus 
characterized as an agent not mutagenic in these conditions. 
Further studies of toxicity need to be made to the use of 
this plant in the treatment of diseases to be stimulated.
Table 3. Micronucleus frequency in 2000 found peripheral blood 
erythrocytes of mice of different experimental groups.
Experimental group Number of micronucleated erythrocytes (mean±SEM)
Control (water) 12.0±2.64
Cyclophosphamide (50 mg/kg) 43.5±5.89**
M. tenuiflora (100 mg/kg) 8.75±2.12 
M. tenuiflora (200 mg/kg) 9.91±1.06
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